CA1340875C - Variants des virus lav, leur adn et fractions proteiques et leur utilis ation, en particulier a des fins diagnostiques et dans la preparation de compositions immunogenes - Google Patents

Variants des virus lav, leur adn et fractions proteiques et leur utilis ation, en particulier a des fins diagnostiques et dans la preparation de compositions immunogenes

Info

Publication number: CA1340875C
Authority: CA; Canada
Prior art keywords: lav; viruses; hiv1; virus; dna
Prior art date: 1987-12-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA000554025A

Other languages

English (en)

Inventor

Marc Alizon

Pierre Sonigo

Simon Wain-Hobson

Luc Montagnier

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Institut Pasteur

Original Assignee

Institut Pasteur

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-12-10

Filing date

1987-12-10

Publication date

2000-01-18

1987-12-10 Application filed by Institut Pasteur filed Critical Institut Pasteur

1987-12-10 Priority to CA000554025A priority Critical patent/CA1340875C/fr

2000-01-18 Application granted granted Critical

2000-01-18 Publication of CA1340875C publication Critical patent/CA1340875C/fr

2017-01-18 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

241000700605 Viruses Species 0.000 title claims abstract description 82
230000002163 immunogen Effects 0.000 title claims description 16
239000000203 mixture Substances 0.000 title claims description 11
238000002360 preparation method Methods 0.000 title description 6
235000004252 protein component Nutrition 0.000 title description 2
108020004414 DNA Proteins 0.000 claims abstract description 62
239000000427 antigen Substances 0.000 claims abstract description 23
102000036639 antigens Human genes 0.000 claims abstract description 23
108091007433 antigens Proteins 0.000 claims abstract description 23
108090000623 proteins and genes Proteins 0.000 claims description 74
108090000765 processed proteins & peptides Proteins 0.000 claims description 67
235000018102 proteins Nutrition 0.000 claims description 65
102000004169 proteins and genes Human genes 0.000 claims description 65
102000004196 processed proteins & peptides Human genes 0.000 claims description 49
239000012634 fragment Substances 0.000 claims description 47
238000000034 method Methods 0.000 claims description 45
229920001184 polypeptide Polymers 0.000 claims description 38
208000030507 AIDS Diseases 0.000 claims description 35
235000001014 amino acid Nutrition 0.000 claims description 34
230000002068 genetic effect Effects 0.000 claims description 22
125000003275 alpha amino acid group Chemical group 0.000 claims description 21
108091028043 Nucleic acid sequence Proteins 0.000 claims description 19
241000282414 Homo sapiens Species 0.000 claims description 18
238000006467 substitution reaction Methods 0.000 claims description 16
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 15
108090000288 Glycoproteins Proteins 0.000 claims description 14
102000003886 Glycoproteins Human genes 0.000 claims description 14
239000000523 sample Substances 0.000 claims description 14
125000000266 alpha-aminoacyl group Chemical group 0.000 claims description 12
238000001514 detection method Methods 0.000 claims description 12
101710112672 Probable tape measure protein Proteins 0.000 claims description 11
230000015572 biosynthetic process Effects 0.000 claims description 11
238000009396 hybridization Methods 0.000 claims description 10
108700026244 Open Reading Frames Proteins 0.000 claims description 9
239000002299 complementary DNA Substances 0.000 claims description 9
241000713772 Human immunodeficiency virus 1 Species 0.000 claims description 8
210000004369 blood Anatomy 0.000 claims description 8
239000008280 blood Substances 0.000 claims description 8
239000002243 precursor Substances 0.000 claims description 7
210000001124 body fluid Anatomy 0.000 claims description 6
239000010839 body fluid Substances 0.000 claims description 6
239000003153 chemical reaction reagent Substances 0.000 claims description 6
238000000338 in vitro Methods 0.000 claims description 6
101710121417 Envelope glycoprotein Proteins 0.000 claims description 5
238000005406 washing Methods 0.000 claims description 5
108060003951 Immunoglobulin Proteins 0.000 claims description 4
102000018358 immunoglobulin Human genes 0.000 claims description 4
238000004448 titration Methods 0.000 claims description 4
101800001690 Transmembrane protein gp41 Proteins 0.000 claims description 3
239000000872 buffer Substances 0.000 claims description 3
229940072221 immunoglobulins Drugs 0.000 claims description 3
102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 2
238000009007 Diagnostic Kit Methods 0.000 claims description 2
238000000151 deposition Methods 0.000 claims description 2
102100021696 Syncytin-1 Human genes 0.000 claims 1
230000008105 immune reaction Effects 0.000 claims 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
208000011580 syndromic disease Diseases 0.000 abstract description 7
230000001506 immunosuppresive effect Effects 0.000 abstract description 2
210000004027 cell Anatomy 0.000 description 32
241000725303 Human immunodeficiency virus Species 0.000 description 27
241001430294 unidentified retrovirus Species 0.000 description 26
229940024606 amino acid Drugs 0.000 description 25
150000001413 amino acids Chemical class 0.000 description 20
101710116435 Outer membrane protein Proteins 0.000 description 17
239000002773 nucleotide Substances 0.000 description 14
125000003729 nucleotide group Chemical group 0.000 description 13
210000001519 tissue Anatomy 0.000 description 13
239000013598 vector Substances 0.000 description 13
125000003277 amino group Chemical group 0.000 description 11
238000003786 synthesis reaction Methods 0.000 description 11
238000012217 deletion Methods 0.000 description 10
230000003612 virological effect Effects 0.000 description 10
102100034349 Integrase Human genes 0.000 description 9
230000037430 deletion Effects 0.000 description 9
238000003780 insertion Methods 0.000 description 9
230000037431 insertion Effects 0.000 description 9
206010001513 AIDS related complex Diseases 0.000 description 8
102000004190 Enzymes Human genes 0.000 description 8
108090000790 Enzymes Proteins 0.000 description 8
241001136003 Human T-lymphotropic virus 3 Species 0.000 description 8
229940088598 enzyme Drugs 0.000 description 8
238000004519 manufacturing process Methods 0.000 description 8
230000008520 organization Effects 0.000 description 8
239000000047 product Substances 0.000 description 8
208000008771 Lymphadenopathy Diseases 0.000 description 7
101710204224 Tape measure protein Proteins 0.000 description 7
210000004698 lymphocyte Anatomy 0.000 description 7
230000035772 mutation Effects 0.000 description 7
230000008569 process Effects 0.000 description 7
108091008146 restriction endonucleases Proteins 0.000 description 7
238000012216 screening Methods 0.000 description 7
-1 t-butyloxycarbonyl groups Chemical group 0.000 description 7
229960005486 vaccine Drugs 0.000 description 7
108020004635 Complementary DNA Proteins 0.000 description 6
230000027645 antigenic variation Effects 0.000 description 6
238000003776 cleavage reaction Methods 0.000 description 6
208000018555 lymphatic system disease Diseases 0.000 description 6
230000007017 scission Effects 0.000 description 6
LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 5
125000001433 C-terminal amino-acid group Chemical group 0.000 description 5
125000000539 amino acid group Chemical group 0.000 description 5
230000008901 benefit Effects 0.000 description 5
239000013060 biological fluid Substances 0.000 description 5
230000003993 interaction Effects 0.000 description 5
150000002500 ions Chemical class 0.000 description 5
238000002955 isolation Methods 0.000 description 5
210000002845 virion Anatomy 0.000 description 5
241000588724 Escherichia coli Species 0.000 description 4
206010071602 Genetic polymorphism Diseases 0.000 description 4
241000713666 Lentivirus Species 0.000 description 4
206010028980 Neoplasm Diseases 0.000 description 4
108010076504 Protein Sorting Signals Proteins 0.000 description 4
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 4
108010003533 Viral Envelope Proteins Proteins 0.000 description 4
108010067390 Viral Proteins Proteins 0.000 description 4
208000010094 Visna Diseases 0.000 description 4
241000713325 Visna/maedi virus Species 0.000 description 4
239000002253 acid Substances 0.000 description 4
230000000890 antigenic effect Effects 0.000 description 4
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
239000000969 carrier Substances 0.000 description 4
230000001413 cellular effect Effects 0.000 description 4
238000010367 cloning Methods 0.000 description 4
239000007822 coupling agent Substances 0.000 description 4
238000010168 coupling process Methods 0.000 description 4
238000005859 coupling reaction Methods 0.000 description 4
235000018417 cysteine Nutrition 0.000 description 4
239000013604 expression vector Substances 0.000 description 4
230000007614 genetic variation Effects 0.000 description 4
210000004962 mammalian cell Anatomy 0.000 description 4
244000005700 microbiome Species 0.000 description 4
230000003472 neutralizing effect Effects 0.000 description 4
150000007523 nucleic acids Chemical class 0.000 description 4
102000005962 receptors Human genes 0.000 description 4
108020003175 receptors Proteins 0.000 description 4
229920005989 resin Polymers 0.000 description 4
239000011347 resin Substances 0.000 description 4
210000002966 serum Anatomy 0.000 description 4
239000000758 substrate Substances 0.000 description 4
108091005703 transmembrane proteins Proteins 0.000 description 4
102000035160 transmembrane proteins Human genes 0.000 description 4
241000713730 Equine infectious anemia virus Species 0.000 description 3
241000701959 Escherichia virus Lambda Species 0.000 description 3
241000598436 Human T-cell lymphotropic virus Species 0.000 description 3
241000713821 Mason-Pfizer monkey virus Species 0.000 description 3
241000288906 Primates Species 0.000 description 3
108020004511 Recombinant DNA Proteins 0.000 description 3
238000002105 Southern blotting Methods 0.000 description 3
102000018265 Virus Receptors Human genes 0.000 description 3
108010066342 Virus Receptors Proteins 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
238000012512 characterization method Methods 0.000 description 3
230000008878 coupling Effects 0.000 description 3
201000010099 disease Diseases 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
230000000694 effects Effects 0.000 description 3
238000001962 electrophoresis Methods 0.000 description 3
102000037865 fusion proteins Human genes 0.000 description 3
108020001507 fusion proteins Proteins 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
238000011065 in-situ storage Methods 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
238000002372 labelling Methods 0.000 description 3
208000032839 leukemia Diseases 0.000 description 3
238000013507 mapping Methods 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
239000013612 plasmid Substances 0.000 description 3
108700004029 pol Genes Proteins 0.000 description 3
238000001556 precipitation Methods 0.000 description 3
230000001566 pro-viral effect Effects 0.000 description 3
125000006239 protecting group Chemical group 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
230000001177 retroviral effect Effects 0.000 description 3
241000894007 species Species 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
230000014616 translation Effects 0.000 description 3
241000714195 Aids-associated retrovirus Species 0.000 description 2
101710132601 Capsid protein Proteins 0.000 description 2
241000282552 Chlorocebus aethiops Species 0.000 description 2
108020004705 Codon Proteins 0.000 description 2
101710142246 External core antigen Proteins 0.000 description 2
102000001690 Factor VIII Human genes 0.000 description 2
108010054218 Factor VIII Proteins 0.000 description 2
KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
241000700721 Hepatitis B virus Species 0.000 description 2
241000282412 Homo Species 0.000 description 2
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
241000714177 Murine leukemia virus Species 0.000 description 2
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
241000713747 Ovine lentivirus Species 0.000 description 2
208000037581 Persistent Infection Diseases 0.000 description 2
206010035226 Plasma cell myeloma Diseases 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
241001529934 Simian T-lymphotropic virus 3 Species 0.000 description 2
241000714229 Simian retrovirus 1 Species 0.000 description 2
210000001744 T-lymphocyte Anatomy 0.000 description 2
108020005202 Viral DNA Proteins 0.000 description 2
108700005077 Viral Genes Proteins 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
238000013459 approach Methods 0.000 description 2
238000003556 assay Methods 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
229910000389 calcium phosphate Inorganic materials 0.000 description 2
239000001506 calcium phosphate Substances 0.000 description 2
235000011010 calcium phosphates Nutrition 0.000 description 2
150000001718 carbodiimides Chemical class 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
150000001945 cysteines Chemical class 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
230000029087 digestion Effects 0.000 description 2
108700004025 env Genes Proteins 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
238000000605 extraction Methods 0.000 description 2
229960000301 factor viii Drugs 0.000 description 2
239000012530 fluid Substances 0.000 description 2
230000004927 fusion Effects 0.000 description 2
108060003552 hemocyanin Proteins 0.000 description 2
239000012456 homogeneous solution Substances 0.000 description 2
210000004408 hybridoma Anatomy 0.000 description 2
230000003100 immobilizing effect Effects 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
230000028993 immune response Effects 0.000 description 2
230000005847 immunogenicity Effects 0.000 description 2
230000001965 increasing effect Effects 0.000 description 2
230000001926 lymphatic effect Effects 0.000 description 2
210000003563 lymphoid tissue Anatomy 0.000 description 2
239000012528 membrane Substances 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
201000000050 myeloid neoplasm Diseases 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
238000004806 packaging method and process Methods 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
230000001717 pathogenic effect Effects 0.000 description 2
230000002093 peripheral effect Effects 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
230000001681 protective effect Effects 0.000 description 2
238000000159 protein binding assay Methods 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000011084 recovery Methods 0.000 description 2
230000010076 replication Effects 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
230000009466 transformation Effects 0.000 description 2
238000013519 translation Methods 0.000 description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
230000010415 tropism Effects 0.000 description 2
241000712461 unidentified influenza virus Species 0.000 description 2
230000009385 viral infection Effects 0.000 description 2
210000005253 yeast cell Anatomy 0.000 description 2
GWMHBZDOVFZVQC-UHFFFAOYSA-N 1,5,6-trimethylimidazo[4,5-b]pyridin-2-amine Chemical compound N1=C(C)C(C)=CC2=C1N=C(N)N2C GWMHBZDOVFZVQC-UHFFFAOYSA-N 0.000 description 1
ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
241000714235 Avian retrovirus Species 0.000 description 1
208000014644 Brain disease Diseases 0.000 description 1
210000004366 CD4-positive T-lymphocyte Anatomy 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
241000736839 Chara Species 0.000 description 1
108700010070 Codon Usage Proteins 0.000 description 1
102000029816 Collagenase Human genes 0.000 description 1
108060005980 Collagenase Proteins 0.000 description 1
102400000125 Cyclin-dependent kinase 5 activator 1, p25 Human genes 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
208000020401 Depressive disease Diseases 0.000 description 1
QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
238000012286 ELISA Assay Methods 0.000 description 1
208000032274 Encephalopathy Diseases 0.000 description 1
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 1
101710091045 Envelope protein Proteins 0.000 description 1
101710177291 Gag polyprotein Proteins 0.000 description 1
241000720950 Gluta Species 0.000 description 1
VPZXBVLAVMBEQI-VKHMYHEASA-N Glycyl-alanine Chemical compound OC(=O)[C@H](C)NC(=O)CN VPZXBVLAVMBEQI-VKHMYHEASA-N 0.000 description 1
HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical class COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
101150013573 INVE gene Proteins 0.000 description 1
108020005350 Initiator Codon Proteins 0.000 description 1
102100034353 Integrase Human genes 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
102000000588 Interleukin-2 Human genes 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
241001527806 Iti Species 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
208000002180 Laurin-Sandrow syndrome Diseases 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
101710125418 Major capsid protein Proteins 0.000 description 1
101710141347 Major envelope glycoprotein Proteins 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
240000000233 Melia azedarach Species 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
230000004988 N-glycosylation Effects 0.000 description 1
108010079364 N-glycylalanine Proteins 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
108091005461 Nucleic proteins Proteins 0.000 description 1
108010038807 Oligopeptides Proteins 0.000 description 1
102000015636 Oligopeptides Human genes 0.000 description 1
108010058846 Ovalbumin Proteins 0.000 description 1
241000282320 Panthera leo Species 0.000 description 1
241001494479 Pecora Species 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
108010033276 Peptide Fragments Proteins 0.000 description 1
102000007079 Peptide Fragments Human genes 0.000 description 1
208000037062 Polyps Diseases 0.000 description 1
241000206607 Porphyra umbilicalis Species 0.000 description 1
239000004365 Protease Substances 0.000 description 1
101710188315 Protein X Proteins 0.000 description 1
241000714474 Rous sarcoma virus Species 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
108091027544 Subgenomic mRNA Proteins 0.000 description 1
108700026226 TATA Box Proteins 0.000 description 1
241000534944 Thia Species 0.000 description 1
241000607598 Vibrio Species 0.000 description 1
108020000999 Viral RNA Proteins 0.000 description 1
101710201961 Virion infectivity factor Proteins 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
XUGUHTGSMPZQIW-UHFFFAOYSA-N [[4-(4-diazonioiminocyclohexa-2,5-dien-1-ylidene)cyclohexa-2,5-dien-1-ylidene]hydrazinylidene]azanide Chemical compound C1=CC(N=[N+]=[N-])=CC=C1C1=CC=C(N=[N+]=[N-])C=C1 XUGUHTGSMPZQIW-UHFFFAOYSA-N 0.000 description 1
239000012190 activator Substances 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
229960003767 alanine Drugs 0.000 description 1
238000010171 animal model Methods 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
239000003124 biologic agent Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000008827 biological function Effects 0.000 description 1
239000012472 biological sample Substances 0.000 description 1
239000010836 blood and blood product Substances 0.000 description 1
229940125691 blood product Drugs 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
229960002424 collagenase Drugs 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical class BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
230000000120 cytopathologic effect Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
125000005442 diisocyanate group Chemical group 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
241001493065 dsRNA viruses Species 0.000 description 1
238000001493 electron microscopy Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
208000019387 endemic Kaposi sarcoma Diseases 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
108010078428 env Gene Products Proteins 0.000 description 1
101150030339 env gene Proteins 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000009585 enzyme analysis Methods 0.000 description 1
RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
230000010429 evolutionary process Effects 0.000 description 1
230000001036 exonucleolytic effect Effects 0.000 description 1
230000006870 function Effects 0.000 description 1
108700004026 gag Genes Proteins 0.000 description 1
108010027225 gag-pol Fusion Proteins Proteins 0.000 description 1
238000007429 general method Methods 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
108010077515 glycylproline Proteins 0.000 description 1
SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 description 1
229940124736 hepatitis-B vaccine Drugs 0.000 description 1
230000000652 homosexual effect Effects 0.000 description 1
230000005099 host tropism Effects 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
230000036039 immunity Effects 0.000 description 1
230000000043 immunodepressive effect Effects 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
239000003999 initiator Substances 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
230000007775 late Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
102000006240 membrane receptors Human genes 0.000 description 1
108020004084 membrane receptors Proteins 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
230000009456 molecular mechanism Effects 0.000 description 1
239000000178 monomer Substances 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
201000008585 noma Diseases 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
229940092253 ovalbumin Drugs 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
101150088264 pol gene Proteins 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
239000002952 polymeric resin Substances 0.000 description 1
108091033319 polynucleotide Proteins 0.000 description 1
102000040430 polynucleotide Human genes 0.000 description 1
239000002157 polynucleotide Substances 0.000 description 1
230000002028 premature Effects 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
230000001915 proofreading effect Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
229940070376 protein Drugs 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
210000004989 spleen cell Anatomy 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
210000001913 submandibular gland Anatomy 0.000 description 1
239000013589 supplement Substances 0.000 description 1
229920003002 synthetic resin Polymers 0.000 description 1
230000005100 tissue tropism Effects 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
238000009966 trimming Methods 0.000 description 1
101150076562 virB gene Proteins 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Hematology (AREA)
AIDS & HIV (AREA)
Urology & Nephrology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Tropical Medicine & Parasitology (AREA)
Pathology (AREA)
General Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Cell Biology (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

CA000554025A 1987-12-10 1987-12-10 Variants des virus lav, leur adn et fractions proteiques et leur utilis ation, en particulier a des fins diagnostiques et dans la preparation de compositions immunogenes Expired - Lifetime CA1340875C (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000554025A CA1340875C (fr)	1987-12-10	1987-12-10	Variants des virus lav, leur adn et fractions proteiques et leur utilis ation, en particulier a des fins diagnostiques et dans la preparation de compositions immunogenes

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA000554025A CA1340875C (fr)	1987-12-10	1987-12-10	Variants des virus lav, leur adn et fractions proteiques et leur utilis ation, en particulier a des fins diagnostiques et dans la preparation de compositions immunogenes

Publications (1)

Publication Number	Publication Date
CA1340875C true CA1340875C (fr)	2000-01-18

Family

ID=33315105

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000554025A Expired - Lifetime CA1340875C (fr)	1987-12-10	1987-12-10	Variants des virus lav, leur adn et fractions proteiques et leur utilis ation, en particulier a des fins diagnostiques et dans la preparation de compositions immunogenes

Country Status (1)

Country	Link
CA (1)	CA1340875C (fr)

1987
- 1987-12-10 CA CA000554025A patent/CA1340875C/fr not_active Expired - Lifetime

Legal Events

Date	Code	Title	Description
2017-03-22	MKEX	Expiry	Effective date: 20170118

Publication	Publication Date	Title
US6426073B1 (en)	2002-07-30	Variant of LAV viruses
Alizon et al.	1986	Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients
US5869631A (en)	1999-02-09	Variant of LAV viruses
EP0345375B1 (fr)	1995-03-22	Rétrovirus HIV-3 et son utilisation
EP0201540B2 (fr)	2001-10-31	Antigenes d'enveloppe du virus des lymphadenopathies et leurs applications
CA2202408C (fr)	2012-03-06	Sequences nucleotidiques d'antigenes retroviraux vih-1 groupe (ou sous-groupe) o
US6037165A (en)	2000-03-14	Methods for the preparation of human immunodeficiency virus type 2 (HIV-2) and antigens encoped thereby
US6730304B2 (en)	2004-05-04	Variant of LAV viruses
US5843638A (en)	1998-12-01	Nucleic acids and pepties of human immunodeficiency virus type-1 (HIV-1).
US5019510A (en)	1991-05-28	Isolation, molecular cloning and sequencing of an HIV-1 isolate from a Gabonese donor
Devare et al.	1986	Genomic diversity of the acquired immunodeficiency syndrome retroviruses is reflected in alteration of its translational products.
CA1340875C (fr)	2000-01-18	Variants des virus lav, leur adn et fractions proteiques et leur utilis ation, en particulier a des fins diagnostiques et dans la preparation de compositions immunogenes
DK176153B1 (da)	2006-10-16	Protein- eller glycoproteinfragment
HK1001233B (en)	1998-06-05	Variants of lav viruses, their dna- and protein components and their uses, particularly for diagnostic purposes and for the preparation of immunogenic compositions
HK1001233A (en)	1998-06-05	Variants of lav viruses, their dna- and protein components and their uses, particularly for diagnostic purposes and for the preparation of immunogenic compositions
HK58597A (en)	1997-05-09	HIV-3 retrovirus and its use